Second-harmonic signaling used to study corneal structure, function

Article

Second-harmonic signaling with the femtosecond laser (IntraLase, Advanced Medical Optics) can be used to probe corneal structure and function. In combination with laser-induced optical breakdown, it also can help create three-dimensional measures of elasticity as well as provide details on the biomechanical properties of the eye, according to James V. Jester, PhD, professor of ophthalmology, University of California, Irvine.

Second-harmonic signaling with the femtosecond laser (IntraLase, Advanced Medical Optics) can be used to probe corneal structure and function. In combination with laser-induced optical breakdown, it also can help create three-dimensional measures of elasticity as well as provide details on the biomechanical properties of the eye, according to James V. Jester, PhD, professor of ophthalmology, University of California, Irvine.

Various groups have studied second-harmonic signaling with the femtosecond laser, mostly in animal models, he said. Studies of this technology in humans have begun to appear, however, including two recent papers that looked at keratoconus.

Both back- and forward-scattered views of the collagen structure can be obtained, although the back-scattered mode is more clinically significant, Dr. Jester said. He and others have examined sutural collagen lamellae and have found that short filaments extend deeply into the anterior portion of the cornea. In a study in six normal patients, investigators found a high amount of sutural lamellae within the cornea. In all but one of 13 eyes with keratoconus, however, the sutural lamellae did not extend and insert into the Bowman's membrane as in the eyes of normal patients; one eye had no sutural lamellae.

"We think that the lamella are lost, either developmentally or prior to progress of the disease, and this may alter the biomechanical properties of the anterior part of the cornea, which leads to the development of keratoconus," Dr. Jester said.

Femtosecond laser second-harmonic signaling also is being used to investigate corneal fibrosis and evaluate the optic nerve head and lamina cribrosa.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.